Li Kang Biomedical Co., Ltd. 6242.TWO Stock
Li Kang Biomedical Co., Ltd. Price Chart
Li Kang Biomedical Co., Ltd. 6242.TWO Financial and Trading Overview
| Li Kang Biomedical Co., Ltd. stock price | 52.8 TWD |
| Previous Close | 72.5 TWD |
| Open | 73 TWD |
| Bid | 72.4 TWD x 0 |
| Ask | 72.5 TWD x 0 |
| Day's Range | 72.2 - 73 TWD |
| 52 Week Range | 43.1 - 82 TWD |
| Volume | 48.68K TWD |
| Avg. Volume | 156.05K TWD |
| Market Cap | 1.69B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 13.016157 |
| EPS (TTM) | 4.77 TWD |
| Forward Dividend & Yield | 1.5 (2.02%) |
| Ex-Dividend Date | June 30, 2023 |
| 1y Target Est | N/A |
6242.TWO Valuation Measures
| Enterprise Value | 1.42B TWD |
| Trailing P/E | 13.016157 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.2875896 |
| Price/Book (mrq) | 2.8324738 |
| Enterprise Value/Revenue | 1.928 |
| Enterprise Value/EBITDA | 8.673 |
Trading Information
Li Kang Biomedical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 44.44% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 82 TWD |
| 52 Week Low | 43.1 TWD |
| 50-Day Moving Average | 74.15 TWD |
| 200-Day Moving Average | 57.71 TWD |
6242.TWO Share Statistics
| Avg. Volume (3 month) | 156.05K TWD |
| Avg. Daily Volume (10-Days) | 99.2K TWD |
| Shares Outstanding | 23.31M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 72.36% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 2.75% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.27879998 |
| Last Split Factor | 1150:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 17.09% |
| Operating Margin (ttm) | 20.76% |
| Gross Margin | 57.01% |
| EBITDA Margin | 22.23% |
Management Effectiveness
| Return on Assets (ttm) | 14.22% |
| Return on Equity (ttm) | 22.89% |
Income Statement
| Revenue (ttm) | 738.76M TWD |
| Revenue Per Share (ttm) | 31.68 TWD |
| Quarterly Revenue Growth (yoy) | 53.80% |
| Gross Profit (ttm) | 388.58M TWD |
| EBITDA | 164.22M TWD |
| Net Income Avi to Common (ttm) | 126.3M TWD |
| Diluted EPS (ttm) | 5.57 |
| Quarterly Earnings Growth (yoy) | 101.89% |
Balance Sheet
| Total Cash (mrq) | 292.34M TWD |
| Total Cash Per Share (mrq) | 12.57 TWD |
| Total Debt (mrq) | 0 TWD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.847 |
| Book Value Per Share (mrq) | 25.596 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 170.23M TWD |
| Levered Free Cash Flow (ttm) | 137.92M TWD |
Profile of Li Kang Biomedical Co., Ltd.
| Country | Taiwan |
| State | N/A |
| City | Tainan City |
| Address | No. 29, Huangong Road |
| ZIP | 710 |
| Phone | 886 6 233 7068 |
| Website | https://www.likangbio.com |
| Industry | Travel Services |
| Sector(s) | Consumer Cyclical |
| Full Time Employees | 122 |
Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drinks. It also engages in management and consulting of tourism factory business; and offers telemarketing services. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd. in September 2014. Li Kang Biomedical Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.
Q&A For Li Kang Biomedical Co., Ltd. Stock
What is a current 6242.TWO stock price?
Li Kang Biomedical Co., Ltd. 6242.TWO stock price today per share is 52.8 TWD.
How to purchase Li Kang Biomedical Co., Ltd. stock?
You can buy 6242.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Li Kang Biomedical Co., Ltd.?
The stock symbol or ticker of Li Kang Biomedical Co., Ltd. is 6242.TWO.
Which industry does the Li Kang Biomedical Co., Ltd. company belong to?
The Li Kang Biomedical Co., Ltd. industry is Travel Services.
How many shares does Li Kang Biomedical Co., Ltd. have in circulation?
The max supply of Li Kang Biomedical Co., Ltd. shares is 32.72M.
What is Li Kang Biomedical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Li Kang Biomedical Co., Ltd. PE Ratio is 11.06918200 now.
What was Li Kang Biomedical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Li Kang Biomedical Co., Ltd. EPS is 4.77 TWD over the trailing 12 months.
Which sector does the Li Kang Biomedical Co., Ltd. company belong to?
The Li Kang Biomedical Co., Ltd. sector is Consumer Cyclical.